Texas SB2916 mandates informed consent for blood tests in medical screenings for sexually transmitted diseases, with an opt-out option for patients.
Texas SB2916 amends the Health and Safety Code to require health care providers to obtain informed consent from patients before conducting blood tests as part of medical screenings for sexually transmitted diseases. Patients must be informed that the test will be performed unless they opt out. If a patient receives a positive test result, the health care provider must inform them of available health care, education, prevention, and social support services.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.